Table 3. Changes in the body composition measured by bioelectrical impedance analysis system.
Variable | Placebo (n = 37) | Collagen (n = 37) | p value† | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Baseline | 12 weeks | Changes | p value* | Baseline | 12 weeks | Changes | p value* | ||||
Weight (kg) | 65.1 ± 8.1 | 65.0 ± 8.5 | −0.1 ± 1.5 | 0.739 | 64.3 ± 8.1 | 63.8 ± 8.0 | −0.5 ± 1.4 | 0.048‡ | 0.260 | ||
BMI (kg/m2) | 25.7 ± 2.3 | 25.7 ± 2.3 | −0.1 ± 0.6 | 0.647 | 25.9 ± 2.0 | 25.6 ± 2.0 | −0.2 ± 0.6 | 0.022‡ | 0.204 | ||
WHR | 0.91 ± 0.05 | 0.90 ± 0.04 | −0.00 ± 0.02 | 0.170 | 0.92 ± 0.04 | 0.91 ± 0.04 | −0.01 ± 0.02 | 0.002§ | 0.146 | ||
Visceral fat area (m2) | 110.5 ± 29.3 | 108.1 ± 27.6 | −2.4 ± 8.3 | 0.084 | 116.3 ± 32.3 | 110.6 ± 29.2 | −5.7 ± 8.7 | 0.000∥ | 0.106 | ||
Fat-free mass (kg) | 42.5 ± 7.0 | 42.7 ± 7.1 | 0.2 ± 0.9 | 0.246 | 41.2 ± 7.0 | 41.4 ± 6.9 | 0.2 ± 1.95 | 0.131 | 0.753 | ||
Skeletal muscle mass (kg) | 23.2 ± 4.2 | 23.3 ± 4.3 | 0.1 ± 0.5 | 0.350 | 22.4 ± 4.3 | 22.6 ± 4.2 | 0.1 ± 0.6 | 0.147 | 0.643 | ||
Fat mass | |||||||||||
Whole body | |||||||||||
Body fat mass (kg) | 22.5 ± 4.6 | 22.5 ± 4.5 | −0.0 ± 1.2 | 0.881 | 23.1 ± 4.9 | 22.4 ± 4.5 | −0.7 ± 1.2 | 0.002§ | 0.021‡ | ||
Percent body fat (%) | 34.8 ± 5.6 | 34.4 ± 5.2 | −0.3 ± 1.3 | 0.121 | 36.0 ± 5.9 | 35.2 ± 5.6 | −0.8 ± 1.5 | 0.002§ | 0.148 | ||
Trunk | |||||||||||
Body fat mass (kg) | 11.6 ± 2.4 | 11.4 ± 2.3 | −0.2 ± 0.7 | 0.159 | 11.9 ± 2.3 | 11.4 ± 2.1 | −0.4 ± 0.7 | 0.001§ | 0.100 | ||
Percent body fat (%) | 249.9 ± 52.9 | 247.2 ± 53.3 | −2.7 ± 15.2 | 0.285 | 260.9 ± 47.2 | 251.6 ± 44.5 | −9.3 ± 14.7 | 0.000∥ | 0.064 |
Data are presented as means ± standard deviations.
The participants take the collagen peptide supplement (15 g/day) or placebo once daily during the 12-week intervention period.
BMI, body mass index; WHR, waist–hip ratio.
*Significance was determined by the paired t-test, p < 0.05; †Significance was determined by the independent t-test, p < 0.05; ‡p < 0.05; §p < 0.01; ∥p < 0.001.